Puneet Souda
Stock Analyst at Leerink Partners
(1.59)
# 3,241
Out of 4,876 analysts
213
Total ratings
47.98%
Success rate
-1.36%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QTRX Quanterix | Downgrades: Market Perform | $12 → $8 | $6.65 | +20.30% | 12 | Apr 30, 2025 | |
| NEO NeoGenomics | Downgrades: Market Perform | $25 → $9 | $7.17 | +25.52% | 10 | Apr 30, 2025 | |
| HOLX Hologic | Downgrades: Market Perform | $80 → $75 | $65.01 | +15.37% | 7 | Feb 6, 2025 | |
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $5.25 | +300.00% | 7 | Dec 9, 2024 | |
| MASS 908 Devices | Downgrades: Market Perform | $12 → $4 | $6.73 | -40.56% | 6 | Nov 13, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $27.38 | +46.09% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $167.96 | -10.69% | 7 | Oct 17, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $352.41 | +6.41% | 15 | Aug 1, 2024 | |
| CYRX Cryoport | Downgrades: Market Perform | $30 → $10 | $7.41 | +34.95% | 6 | Jul 13, 2023 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $630 | $408.28 | +54.31% | 19 | Jul 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $35 | $20.35 | +71.99% | 11 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $145 | $119.17 | +21.67% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $198.80 | +50.91% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $94.79 | +163.74% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $51.84 | +112.19% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $53.65 | +39.79% | 16 | Jan 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $123.56 | +61.86% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $3.61 | +398.61% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $1.70 | +252.94% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $35.93 | -16.50% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $41.80 | +108.13% | 13 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $140 | $50.86 | +175.27% | 5 | Feb 24, 2022 |
Quanterix
Apr 30, 2025
Downgrades: Market Perform
Price Target: $12 → $8
Current: $6.65
Upside: +20.30%
NeoGenomics
Apr 30, 2025
Downgrades: Market Perform
Price Target: $25 → $9
Current: $7.17
Upside: +25.52%
Hologic
Feb 6, 2025
Downgrades: Market Perform
Price Target: $80 → $75
Current: $65.01
Upside: +15.37%
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $5.25
Upside: +300.00%
908 Devices
Nov 13, 2024
Downgrades: Market Perform
Price Target: $12 → $4
Current: $6.73
Upside: -40.56%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $27.38
Upside: +46.09%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $167.96
Upside: -10.69%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $352.41
Upside: +6.41%
Cryoport
Jul 13, 2023
Downgrades: Market Perform
Price Target: $30 → $10
Current: $7.41
Upside: +34.95%
Thermo Fisher Scientific
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $408.28
Upside: +54.31%
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $20.35
Upside: +71.99%
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $119.17
Upside: +21.67%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $198.80
Upside: +50.91%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $94.79
Upside: +163.74%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $51.84
Upside: +112.19%
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $53.65
Upside: +39.79%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $123.56
Upside: +61.86%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $3.61
Upside: +398.61%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $1.70
Upside: +252.94%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $35.93
Upside: -16.50%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $41.80
Upside: +108.13%
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $50.86
Upside: +175.27%